Diabetes drug showdown: which pill wins for blood pressure?
NCT ID NCT07541456
First seen Apr 29, 2026 · Last updated Apr 29, 2026
Summary
This study tested whether empagliflozin, a diabetes medication, lowers blood pressure more than other standard diabetes pills in adults with type 2 diabetes and high blood pressure. 300 participants took either empagliflozin or another diabetes drug for 12 weeks. Researchers measured blood pressure changes from start to finish to see which treatment worked better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shahida Islam Medical College, Lodhran
Lodhran, Punjab Province, Pakistan
Conditions
Explore the condition pages connected to this study.